Lab
Beta Diagnostic Labs LLC
Beta Diagnostic Labs LLC was paid $8.44M by Medicaid between Jun 2022 and Jun 2024, across 27 billing codes. Its largest line is 87637, Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV — 57% of everything it billed.
33Billing provider infoBETA DIAGNOSTIC LABS LLC
MT PLEASANT, WI 53406
MT PLEASANT, WI 53406
33aNPI1457003329assigned 01/21/2022
33bProvider typeClinical Medical Laboratory
28Total paid$8.44M
24GClaims254,489
24DCodes billed27
24AFirst – last monthJun 2022 – Jun 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Wisconsin
Rank by total paid#8 of 75
Median peer was paid$106K
This provider vs. median79×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2022 | 45,529 | $1.43M | |
| 2023 | 205,234 | $6.95M | |
| 2024incomplete | 3,726 | $67K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 57% | 51,495 | 10,280 | $4.80M |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 8.5% | 22,839 | 4,586 | $714K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 7.2% | 18,024 | 4,420 | $609K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 6.8% | 16,796 | 4,235 | $578K |
| 87634 | 5.2% | 18,043 | 4,415 | $435K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 4.0% | 50,844 | 9,145 | $338K |
| 87581 | 2.8% | 18,284 | 4,623 | $236K | |
| 87486 | 2.7% | 17,905 | 4,591 | $230K | |
| 87541 | 2.7% | 17,956 | 4,593 | $228K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 2.1% | 17,141 | 4,271 | $180K |
| 87640 | <1% | 1,834 | 1,043 | $26K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 328 | 128 | $15K |
15 more codes
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 300 | $12K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 362 | $6K |
| 87536 | <1% | 189 | $3K | |
| 87529 | <1% | 92 | $3K | |
| 87625 | <1% | 207 | $3K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 205 | $3K |
| 87623 | <1% | 207 | $3K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 205 | $3K |
| 87496 | <1% | 203 | $3K | |
| 87517 | <1% | 175 | $2K | |
| 87522 | Neg quan hep c or qual rna | <1% | 190 | $2K |
| 87497 | <1% | 194 | $2K | |
| 87521 | Neg quan hep c or qual rna | <1% | 200 | $2K |
| 87516 | <1% | 185 | $2K | |
| 87535 | <1% | 86 | $1K |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTOUSIS, TOM (OWNER)